Addressing Determinants of Immunization Inequities Requires Objective Tools to Devise Local Solutions.

European Immunization Agenda 2030 immunization inequities local determinants operational guidance pragmatic

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
06 Apr 2023
Historique:
received: 28 02 2023
revised: 28 03 2023
accepted: 03 04 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Universal immunization substantially reduces morbidity and mortality from vaccine-preventable diseases. In recent years, routine immunization coverage has varied considerably among countries across the WHO European Region, and among different populations and districts within countries. It has even declined in some countries. Sub-optimal immunization coverage contributes to accumulations of susceptible individuals and can lead to outbreaks of vaccine-preventable diseases. The European Immunization Agenda 2030 (EIA2030) seeks to build better health in the WHO European Region by ensuring equity in immunization and supporting immunization stakeholders in devising local solutions to local challenges. The factors that influence routine immunization uptake are context specific and multifactorial; addressing immunization inequities will require overcoming or removing barriers to vaccination for underserved individuals or populations. Local level immunization stakeholders must first identify the underlying causes of inequities, and based on this information, tailor resources, or service provision to the local context, as per the organization and characteristics of the health care system in their countries. To do this, in addition to using the tools already available to broadly identify immunization inequities at the national and regional levels, they will need new pragmatic guidance and tools to address the identified local challenges. It is time to develop the necessary guidance and tools and support immunization stakeholders at all levels, especially those at the subnational or local health centre levels, to make the vision of EIA2030 a reality.

Identifiants

pubmed: 37112723
pii: vaccines11040811
doi: 10.3390/vaccines11040811
pmc: PMC10145207
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Vaccine. 2018 Oct 29;36(45):6726-6735
pubmed: 30266484
Vaccine. 2018 Jul 25;36(31):4687-4692
pubmed: 29945834
J Epidemiol Community Health. 2017 Jun;71(6):544-549
pubmed: 27531844
J Epidemiol Community Health. 2017 Jan;71(1):87-97
pubmed: 27535769
Expert Rev Vaccines. 2017 Nov;16(11):1107-1118
pubmed: 28914112
Vaccine. 2018 Mar 7;36(11):1509-1515
pubmed: 29287678
Vaccine. 2013 Apr 18;31 Suppl 2:B103-7
pubmed: 23598470
J Infect Dis. 2011 Jul;204 Suppl 1:S353-65
pubmed: 21666185
Public Health. 2019 Jun;171:97-105
pubmed: 31121558
Euro Surveill. 2019 Jan;24(2):
pubmed: 30646979
Hum Vaccin Immunother. 2021 Jul 3;17(7):2008-2017
pubmed: 33605835
Vaccines (Basel). 2022 Jun 28;10(7):
pubmed: 35891201
Vaccine. 2016 May 23;34(24):2635-43
pubmed: 27109562

Auteurs

Siddhartha Sankar Datta (SS)

Vaccine-Preventable Diseases and Immunization Programme, World Health Organization Regional Office for Europe, DK-2100 Copenhagen, Denmark.

Federico Martinón-Torres (F)

Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, 15706 Galicia, Spain.

Nino Berdzuli (N)

Division of Country Health Programmes, World Health Organization Regional Office for Europe, DK-2100 Copenhagen, Denmark.

Niyazi Cakmak (N)

Vaccine-Preventable Diseases and Immunization Programme, World Health Organization Regional Office for Europe, DK-2100 Copenhagen, Denmark.

Michael Edelstein (M)

Azrieli Faculty of Medicine, Bar-Ilan University, Ramat Gan 5290002, Israel.

Simon Cottrell (S)

Vaccine Preventable Disease Programme, Public Health Wales NHS Trust, Cardiff CF10 4BZ, UK.

Mark Muscat (M)

Vaccine-Preventable Diseases and Immunization Programme, World Health Organization Regional Office for Europe, DK-2100 Copenhagen, Denmark.

Classifications MeSH